Multiplex highly sensitive detection of cancer biomarkers in biological samples

15th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2011, MicroTAS 2011

Volumn 1, Issue , 2011, Pages 665-667

  Pekin, D ^a   Skhiri, Y ^a   Baret, J C ^a,c   Le Corre, D ^b   Mazutis, L ^a   Ben Salem, C ^a   El Abed, A ^b   Hutchison, J B ^d   Link, D R ^d   Griffiths, A D ^a   Laurent Puig, P ^b   Taly, V ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c MAX PLANCK INSTITUTE FOR DYNAMICS AND SELF ORGANIZATION   (Germany)

^d RainDance Technologies   (United States)

Author keywords

Biomarkers; Digital PCR; Droplet based microfluidics; Highly sensitive detection; KRAS

Indexed keywords

BIOLOGICAL SAMPLES; CANCER BIOMARKERS; DIGITAL PCR; DROPLET-BASED MICROFLUIDICS; HIGHLY SENSITIVE DETECTIONS; KRAS; MULTIPLEX DETECTIONS; SENSITIVITY AND SPECIFICITY;

BIOMARKERS; CELLS; DIAGNOSIS; DIGITAL MICROFLUIDICS; DNA; GENES; MULTIPLEXING; PATIENT TREATMENT;

POLYMERASE CHAIN REACTION;

EID: 84883821779     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (15)

1. F. Diehl, et al, Circulating mutant DNA to assess tumor dynamics, Nat Med, vol. 14, pp. 985-90, (2008).
2. R. S. Negm, et al, The promise of biomarkers in cancer screening and detection, Trends Mol Med, vol. 8, pp. 288-93, (2002).
3. C. L. Sawyers, The cancer biomarker problem, Nature, vol. 452, pp. 548-52, (2008).
4. L. Johnson, et al, Somatic activation of the K-ras oncogene causes early onset lung cancer in mice, Nature, vol. 410, pp. 1111-6, (2001).
5. A. Russo, et al, Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies, Ann Oncol, vol. 16 Suppl 4, pp. iv44-9, (2005).
6. F. Diehl, et al, Digital quantification of mutant DNA in cancer patients, Curr Opin Oncol, vol. 19, pp. 36-42, (2007).
7. A. C. Tsiatis, et al, Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications, J Mol Diagn, vol. 12, pp. 425-32, (2010).
8. B. Vogelstein, et al, Digital PCR, Proc Natl Acad Sci U S A, vol. 96, pp. 9236-41, (1999).
9. R. Williams, et al, Amplification of complex gene libraries by emulsion PCR, Nat Methods, vol. 3, pp. 545-50, (2006).
10. A. B. Theberge, et al, Microdroplets in microfluidics: an evolving platform for discoveries in chemistry and biology, Angew Chem Int Ed Engl, vol. 49, pp. 5846-68, (2010).
11. A. Lievre, et al, KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab, J Clin Oncol, vol. 26, pp. 374-9, (2008).
12. D. Pekin, et al, Droplet-based microfluidics for the quantitative detection of rare mutations, Proc. MicroTas 2010, Groningen, The Netherlands., pp. 58-60.
13. D. Pekin, et al, Quantitative and sensitive detection of rare mutations using droplet-based microfluidics, Lab Chip, vol., pp. 2156-2166, (2011).
14. C. Holtze, et al, Biocompatible surfactants for water-in-fluorocarbon emulsions, Lab Chip, vol. 8, pp. 1632-9, (2008).
15. L. Mazutis, et al, Multi-step microfluidic droplet processing: kinetic analysis of an in vitro translated enzyme, Lab on a Chip, vol. 9, pp. 2902-8, (2009).